Chabiotech Co Ltd 085660
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- KRW 17,190.00
- Day Range
- KRW 16,950.00–17,140.00
- 52-Week Range
- —–—
- Bid/Ask
- KRW 17,010.00 / KRW 17,190.00
- Market Cap
- KRW 968.05 Bil
- Volume/Avg
- 109,477 / 471,817
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1.07
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- 0.31%
Company Profile
Chabiotech Co Ltd is engaged in the manufacturing of biological products.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Mid Core
- Total Number of Employees
- 278
- Website
- http://en.chabio.com
Comparables
Valuation
|
Metric
|
085660
|
107590
|
094360
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 11.85 | 41.64 |
Price/Book Value | 3.44 | 0.77 | 6.25 |
Price/Sales | 1.07 | 0.40 | 15.08 |
Price/Cash Flow | 36.56 | 8.94 | 33.84 |
Price/Earnings
085660
107590
094360
Financial Strength
|
Metric
|
085660
|
107590
|
094360
|
|---|---|---|---|
Quick Ratio | 0.73 | 0.65 | 10.04 |
Current Ratio | 0.83 | 1.23 | 10.09 |
Interest Coverage | 0.67 | 4.42 | −72.34 |
Quick Ratio
085660
107590
094360
Profitability
|
Metric
|
085660
|
107590
|
094360
|
|---|---|---|---|
Return on Assets (Normalized) | −0.51% | 3.42% | 14.46% |
Return on Equity (Normalized) | −2.90% | 7.38% | 21.37% |
Return on Invested Capital (Normalized) | 0.33% | 5.39% | 17.75% |
Return on Assets
085660
107590
094360
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Fdpjqdhww | Lgpn | $562.4 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Xcgdvpbs | Dnslpxk | $103.6 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Ckggxnp | Vqkltl | $99.5 Bil | |
MRNA
| Moderna Inc | Mlcctmbmf | Yswq | $38.8 Bil | |
ARGX
| argenx SE ADR | Rwwzbht | Kgj | $22.3 Bil | |
BNTX
| BioNTech SE ADR | Sczvdbthp | Qgtcp | $21.2 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Vpxflpf | Bfjkkkc | $18.2 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Qtlwtcl | Mkwwng | $17.3 Bil | |
RPRX
| Royalty Pharma PLC Class A | Qwxrkgccv | Kcxcv | $12.5 Bil | |
INCY
| Incyte Corp | Fnxsjtmtn | Fxpqzw | $11.6 Bil |